Compounds with biological roles [BR:br08001]
Steroids
24-Carbon atoms
Cholane derivatives
C00695 Cholic acid
Lipids [BR:br08002]
ST Sterol lipids
ST04 Bile acids and derivatives
ST0401 C24 bile acids, alcohols, and derivatives
C00695 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A05 BILE AND LIVER THERAPY
A05A BILE THERAPY
A05AA Bile acids and derivatives
A05AA03 Cholic acid
D10699 Cholic acid (JAN/USAN) <JP/US>
USP drug classification [BR:br08302]
Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
Cholic Acid
D10699 Cholic acid (JAN/USAN)
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
39 Other agents affecting metabolism
399 Miscellaneous
3999 Others
D10699 Cholic acid (JAN/USAN)
Risk category of Japanese OTC drugs [BR:br08312]
Third-class OTC drugs
Inorganic and organic chemicals
Cholic acid
C00695 Cholic acid
Drug groups [BR:br08330]
Gastrointestinal agent
DG01956 Bile acid preparation
D10699 Cholic acid
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Thyroid hormone like receptors
Liver X receptor like receptor
NR1H4 (FXR)
D10699 Cholic acid (JAN/USAN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D10699
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D10699
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D10699
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D10699